Latest Isotretinoin Stories

Association of suicide attempts with acne and treatment with isotretinoin: Retrospective Swedish cohort studyIndividuals who suffer from severe acne are at an increased risk of attempting suicide, according to a paper published on bmj.com today.The study also finds that an additional risk may be present during and up to one year after treatment with isotretinoin, a commonly prescribed drug for severe acne. However, the authors stress that this additional risk is most likely due to the acne...

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 29 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug...

Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions. The percentage rose from 46 percent for children receiving a standard therapy to 66 percent for children receiving immunotherapy plus standard therapy, according to the study published in...

New standard of care in high-risk neuroblastoma seen in immunotherapy resultsUsing immunotherapy"”biologic agents that stimulate the body's immune system"”pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved two-year survival rates by 20 percent, compared to standard treatment for an aggressive form of neuroblastoma, a cancer of the nervous...

-- New Standard of Care in High-Risk Neuroblastoma Seen in Immunotherapy Results-- PHILADELPHIA, Sept. 29 /PRNewswire-USNewswire/ -- Using immunotherapy--biologic agents that stimulate the body's immune system--pediatric oncologists have achieved the first substantial increase in over a decade in cure rates for the childhood cancer neuroblastoma. A newly released study shows that the new treatment improved survival rates by 20 percent, compared to standard treatment for an aggressive form...

New research suggests that acne antibiotics prescribed to help control breakouts may lead to inflammatory bowel disease. Dr. David Margolis, a dermatologist and lead author of a study in the American Journal of Gastroenterology, said in an interview with Reuters Health that bowel disorders linked to acne treatment are "a rare outcome."However, previous studies suggest that the acne drug isotretinoin might be the cause of inflammatory bowel disease in a small number of patients...

ATLANTIC CITY, N.J., Feb. 17 /PRNewswire/ -- In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe...

University of Montreal study reveals danger of certain drugsMore than six percent of expectant mothers in Quebec consume prescription drugs that are known to be harmful to their fetuses, according to a Université de Montréal investigation published in the British Journal of Obstetrics and Gynaecology. Half these women will voluntarily terminate their pregnancy fearing congenital malformations, which means the abortion rate among these women is 11 percent higher than in the rest of the...

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 7 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The study is randomized, double-blinded trial comparing the safety profile of CIP-ISOTRETINOIN to an FDA-approved, commercially available isotretinoin...

PLEASANTON, Calif., July 15 /PRNewswire/ -- Roche Holding AG, the world's biggest maker of cancer drugs, recently announced the withdrawal of its Accutane acne medicine from the US Market. The decision was largely driven by falling market share, the product reaching the end of its life cycle, and the high cost of personal injury lawsuits. (i) "While the withdrawal of Accutane comes on the heels of much public scrutiny, the bottom line is that physicians and patients need a viable...